Number of pages: 100 | Report Format: PDF | Published date: April 13, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 496.5 million |
Market Size Value in 2031 |
US$ 824.69 million |
CAGR |
5.8% |
Base Year for Estimation |
2022 |
Forecast Period |
2023-2031 |
Historical Year |
2021 |
Segments Covered |
Product Type, Material Type, Application, End User, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global urinary stents market was valued at US$ 496.5 million in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 824.69 million by 2031.
Urinary Stents Market Fundamentals
Urinary stents are medical devices inserted into the ureter to clear blockages and help urine flow from the kidney to the bladder. They are usually placed when there is a blockage in the ureter that prevents urine from passing through due to conditions such as kidney stones or tumors. The stent is a small, flexible tube made of plastic or metal mesh and placed into the ureter through the bladder. Appropriate placement of urinary stents helps relieve pressure on the kidneys and prevent renal system damage. Urinary stents are typically temporary and usually removed after a few weeks or months.
[56756]
Urinary Stents Market Dynamics
Urological illnesses such as urinary tract infections, kidney stones, bladder control issues, and prostate difficulties are becoming increasingly common among people. The introduction of technical improvements in urinary stent production, an increasing number of kidney transplants, and a growing aged population are all driving the global urinary stent market revenue expansion. A key factor driving urinary stent acceptance and usage is the extensive list of advantages connected with the device. Furthermore, stents aid in the drainage of infected urine in cases of ureteral infection.
The wide application base of urinary stents is a key driver of market revenue. Urinary stents are increasingly being used to treat obstructions that result from inflammatory bowel disease, urinary stones, blood clots, tumors, and scar tissue caused by endometriosis, and inherited conditions such as obstruction of the ureteropelvic junction, which results in narrowing of the ureters. Urinary stents are also often used after urolithiasis treatment when the stones are ruptured into tiny fragments, allowing the ureter to heal properly after intervention.
Medical tourism expansion in developed nations is likely to boost market revenue growth. Furthermore, the increased use of minimally invasive operations is expected to drive the urinary stents market revenue. Growing cases of prostate cancer demanding invasive treatments also indicate the increasing uptake of urinary stents, as a narrowing of the ureter or scarring on the ureter wall often characterizes prostate cancer.
The urinary stent market revenue growth is likely to be hampered by a lack of healthcare personnel who can manage essential treatment procedures and rising adverse effects connected with urinary stents. Some negative effects of urinary stent installation include discomfort, traces of blood, worsening kidney pain, frequent urination, bladder spasms, bladder irritation, painful urination, and even the incidence of urinary tract infections. This can also happen because of blocking, rupturing, or displacing stents or the patient engaging in strenuous activities. Furthermore, the challenges involved with removing the stent are expected to be a challenge for the urinary stents market.
Urinary Stents Market Ecosystem
The global urinary stents market is analyzed from perspectives: product type, material type, application, end-user, and region.
Urinary Stents Market by Product Type
[96765]
Based on product types, the global urinary stents market is segmented into open-ended, close-ended, double pigtail, and multiloop.
The double pigtail stents segment is proven to have a high efficacy in treating a variety of urological conditions. Healthcare professionals often prefer these stents because they are effective at relieving ureteral obstruction and preventing the formation of kidney stones. The double pigtail stents segment is flexible and can conform to the shape of the ureter, making them more comfortable for patients to wear. This flexibility also makes them easier to insert and remove. Double pigtail stents are made from materials that are durable and resistant to degradation. This means that they can remain in the body for longer periods without needing to be replaced. These devices are widely available and come in a range of sizes, making them suitable for use in various patients with different anatomies. Double pigtail stents are generally less expensive than other types of stents, which makes them a cost-effective option for healthcare providers. All these factors support the rapid revenue growth rate of the double pigtail stents segment.
Urinary Stents Market by Material Type
Based on the material type, the global urinary stents market is segmented into silicon, polyurethane, metal stents, hydrogel, and others.
The polyurethane segment dominates the global urinary stents market due to several reasons. Firstly, polyurethane is a biocompatible material well-tolerated by the human body, which is essential for medical devices implanted inside the body. Secondly, polyurethane stents are flexible, which allows for better patient comfort and reduces the risk of stent migration or dislodgement. Thirdly, polyurethane stents have a lower risk of encrustation, which is the buildup of mineral deposits on the surface of the stent that can cause complications. Finally, polyurethane stents are easy to manufacture and relatively cheap compared to other materials such as metal or silicone. This makes them a cost-effective option for healthcare providers and patients.
Due to several factors, the metallic stents segment also accounts for a notable revenue share in the global urinary stents market. One of the primary reasons is that metallic stents offer several advantages over traditional polymer or silicone stents. Metallic stents have a longer lifespan than traditional stents. They can remain in the body for extended periods, reducing the need for repeated stent replacement procedures. This can result in significant cost savings for patients and healthcare providers.
Moreover, metallic stents have a larger diameter than traditional stents, allowing for better drainage and increased urine flow. This can reduce the risk of infection and other complications, such as blockages and kidney damage. Additionally, metallic stents are less likely to migrate or move from their intended location, reducing the need for additional surgical interventions to reposition or remove the stent. Metallic stents are also more resistant to kinking or collapsing, which can occur with traditional stents. This ensures that the stent remains open and functional, improving patient outcomes.
Urinary Stents Market by Application
Based on the application, the global urinary stents market is segmented into tumors, kidney transplantation, kidney stones, urinary incontinence, and others.
Kidney stone segment accounts for the largest revenue share in the urinary stents market. Kidney stones are a common health problem, affecting millions worldwide. Ureteral stents are often used to treat kidney stones, contributing to the dominance of the kidney stone segment in the global market. Ureteral stents are a minimally invasive option for treating kidney stones, which patients and healthcare providers increasingly prefer. This has led to a growing demand for urinary stents in the kidney stone segment. Advances in technology have led to the development of better urinary stents that are more effective in treating kidney stones. This has further contributed to the dominance of the kidney stone segment in the global urinary stents market in terms of the largest revenue share. Reimbursement policies for ureteral stents vary by country and by indication. In many cases, reimbursement for urinary stents is only available for certain indications, such as kidney stones. This has also contributed to the dominance of urinary stents for the kidney stone segment.
Urinary Stents Market by End User
Based on the end users, the global urinary stents market is segmented into hospitals, ambulatory surgical centers, and others.
The hospital segment registered the largest revenue share in 2022 in the global market. Hospitals perform a high volume of procedures, including urinary stent placement, which drives the demand for urinary stents in the hospital segment. Hospitals have skilled healthcare professionals, such as urologists, who are trained to perform urinary stent placement procedures. The collective expertise in hospitals enables effective diagnosis and treatment of a wide range of urological disorders, boosting the urinary stents uptake. Hospitals have access to advanced stent technology and imaging equipment, enabling them to accurately place and monitor the stents. This improves patient outcomes and further drives the demand for urinary stents in the hospital segment. Hospitals have the necessary resources to perform urinary stent placement procedures, such as operating rooms, medical supplies, and post-procedure care. This makes them the primary location for such procedures and drives demand for urinary stents in the hospital segment. Insurance coverage for stenting procedures is more common in hospitals, which further supports high patient footfall in hospitals.
Urinary Stents Market by Region
Based on the region, the global urinary stents market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominates the global urinary stents market, with the largest revenue share in 2022. Due to the lifestyle-associated implications, kidney stones are high in North America, leading to a greater demand for urinary stents to treat ureteral obstruction. North America has a highly developed healthcare system and a strong medical device market. This has led to the development and adoption of advanced stent technology, further boosting the demand for urinary stents in the region. North America has a higher per capita healthcare spending than other regions, enabling patients to afford expensive procedures such as stent placement. Additionally, insurance coverage for medical procedures is more common in North America, supporting the demand for urinary stents. Many of the major global urinary stents market players are based in North America, which gives the region an advantage in market dominance. Several market incumbents have a strong regional distribution network and a large customer base, which further drives the demand for urinary stents.
Europe accounts for the largest revenue share in the global market. The incidence of kidney diseases, such as kidney stones and kidney cancer, is increasing in Europe. This has led to a greater demand for urinary stents to treat ureteral obstruction caused by these diseases. European governments have implemented favorable healthcare policies that provide universal healthcare coverage and support innovative medical technologies, including urinary stents. The medical device industry in Europe is highly evolved, and companies are investing in research and development to develop advanced stent technologies. This leads to the development of stents with better biocompatibility, longer lifespan, and improved patient outcomes, further driving demand in the region. The population in Europe is aging, leading to a higher incidence of kidney diseases and other urological disorders, thereby increasing the demand for urinary stents. The major global urinary stents market players have a strong distribution network in Europe, enabling them to effectively reach customers in the region and drive demand for their products.
Competitive Landscape of the Global Urinary Stents Market
The prominent players operating in the global urinary stents market are:
Strategic Developments in the Urinary Stents Market
Urinary stents are structures inserted in the ureter to cure or prevent a blockage that prevents urine from flowing from the kidney to the bladder. The treatment of kidney stones is the most prevalent purpose for urinary stents.
The global urinary stents market is expected to be US$ 824.69 million in 2031.
The factors restraining the revenue growth of the global urinary stents market are the negative effects of urinary stents and the lack of skilled medical professionals.
Urinary stents are expected to grow at a revenue CAGR of 5.89% during the forecast period.
The rise in the prevalence of kidney stones, growth in the geriatric population, advances in device innovation, and rapid growth in R&D activities are some factors driving the global urinary stents market revenue growth.
*Insights on financial performance are subject to the availability of information in the public domain